Search companies or stocks...
CTECryosite Limited
At close · 25 Aug 2026, 03:14 am
Disclaimer: This fair value estimate is for informational purposes only and should not be considered as investment advice. Fair value calculations are based on DCF (Discounted Cash Flow), P/E Multiple, and P/S Multiple models and assumptions that may not reflect actual market conditions. Always conduct your own research and consult with a financial advisor before making investment decisions.
Buy
Based on 0 analysts giving stock ratings to CTE in the past 3 months.
Cryosite Limited offers outsourced clinical trials logistic services in Australia. It operates through two segments, Clinical Trials and Biological Services Logistics, and…
Current stock price of Cryosite Limited (CTE) stock is $1.250. The stock price is +0.00% higher in the session. The intraday range can be seen from this page. Volume of Cryosite Limited (CTE) stock is 13.56K.
Last updated at 25 Aug 2026, 03:14 am.
The stock price of Cryosite Limited (CTE) can change with earnings, company news, and overall market sentiment. Cryosite Limited operates in the Healthcare / Unknown market, so sector-wide moves can also affect the share price. Use the live price, percentage change, and volume on this page to judge whether a move looks meaningful.
Whether Cryosite Limited looks expensive depends on valuation metrics versus its growth outlook. The P/E ratio shown for CTE on this page is 28.48. EPS on this page is 0.04. Compare those figures with peers and growth expectations before deciding if the current Cryosite Limited price is justified.
Historical performance for Cryosite Limited (CTE) is shown on the price chart on this page. Review multi-period moves alongside volume to see how CTE reacted to past earnings and market events.
Buying Cryosite Limited (CTE) depends on your risk tolerance, time horizon, and portfolio needs. As a Healthcare name, weigh the live quote, key stats, and valuation links on this page rather than a single price point.
